ZENEDGE to leverage PCI Compliant Equinix facilities to build additional Mega-POPs; Expansion provides a tenfold increase in capacity to accommodate customer growth; ZENEDGE to make its cybersecurity solutions available via Equinix Marketplace™ LOS ANGELES and AVENTURA, Fla., April 5, 2017 …
Read more »MCLEAN, Va., March 23, 2017 /PRNewswire/ — Perthera, Inc. announced today that they have successfully integrated germline genomic panel testing into its Precision Cancer Analysis (PCA), which provides cancer patients and their health care team a complete and integrated analysis plus …
Read more »SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Counsyl, a DNA testing and genetic counseling service company, welcomes the new carrier screening guidelines issued by the American College of Obstetricians and Gynecologists (ACOG), which, among other guidance, recognizes expanded carrier screening as an acceptable …
Read more »/PRNewswire/ — Perthera, Inc., a McLean, Virginia full-service precision medicine company, today announced that Admiral James A. “Sandy” Winnefeld, Jr., U.S. Navy (retired) is becoming a Senior Advisor to the company. Perthera, which was founded in 2012, leverages biological, computational, …
Read more »All women, regardless of ethnic background, should be offered additional carrier screening prior to pregnancy, said the American College of Obstetricians and Gynecologists. Ethnic-specific screening, pan-ethnic screening, and expanded carrier screening are all acceptable strategies that ob/gyns can use to …
Read more »Fla., Feb. 13, 2017 /PRNewswire/ –RSA Conference 2017 — ZENEDGE, a leading provider of cloud-based, artificial intelligence (AI) driven Web Application Firewall (WAF), malicious bot detection and DDoS cybersecurity solutions, announced today ZENEDGE Bot Manager, a next generation bot management …
Read more »Dr. Chip Petricoin discusses Perthera as a cancer concierge service in the What’s Working in Washington podcast.
Startups like the D.C.-based cancer treatment company Perthera have helped drive the explosive growth in one of the fastest growing sectors in the medical industry – personalized medicine. Perthera specializes in precision cancer analysis. It uses technology to profile the molecules in cancer tumors so as to be able to offer personalized treatment options.
Read more »MANHATTAN BEACH, Calif.–(Business Wire)–The Pancreatic Cancer Action Network announced today that since the 2014 inception of its Know Your TumorSM personalized medicine service, more than 1,000 pancreatic cancer patients have enrolled. To date, approximately 500 of these patients and their …
Read more »Our CoFounder Neill Callahan in TopBots… 15. NEIL CALLAHAN, MANAGING DIRECTOR AT PILOT GROWTH EQUITY Pilot Growth Equity, a growth-stage VC, built their own AI platform NavPod to improve the speed, accuracy, quality, and cost of their deal sourcing. Neil …
Read more »NEW YORK (GenomeWeb) – Perthera said today that it is collaborating with drugmaker Novartis to identify breast and lung cancer patients for clinical trials. Under the collaboration, Novartis will access cancer patients who have used Perthera’s Precision Cancer Analysis (PCA) …
Read more »